SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 12, 2001, Pages 3950-3962

Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides

(13) Miyagi, Yoshiaki a Sasatomi, Teruo a Mine, Takashi a Isomoto, Hiroharu a Shirouzu, Kazuo a Yamana, Hideaki a Imai, Nobue a Yamada, Akira a Katagiri, Kazuko a Muto, Akira a Okouchi, Shinya a Itoh, Kyogo a Nakagawa, Masami a

a KURUME UNIVERSITY SCHOOL OF MEDICINE (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; HLA A2 ANTIGEN; SART3 PEPTIDE; SART3[109-118] PEPTIDE; SART3[315-323] PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL; CANCER IMMUNIZATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; DRUG ERUPTION; DRUG SAFETY; FEMALE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENICITY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PRURITUS; TUMOR IMMUNITY; VACCINE PRODUCTION;

ADULT; AGED; ANTIGENS, NEOPLASM; CANCER VACCINES; COLORECTAL NEOPLASMS; EPITOPES; FEMALE; HLA-A ANTIGENS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NEOPLASM STAGING; RNA-BINDING PROTEINS; SURVIVAL RATE; TIME FACTORS;

EID: 0035679233 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (112)

References (24)

1
- 0026322151
- A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
- (1991) Science (Wash. DC) , vol.254 , pp. 1643-1647
- Van der Bruggen, P.¹ Traversari, C.² Chomez, P.³ Lurquin, C.⁴ De Plaen, E.⁵ Van den Eynde, B.⁶ Knuth, A.⁷ Boon, T.⁸

2
- 0028302028
- Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes
- (1994) J. Exp. Med. , vol.180 , pp. 347-352
- Kawakami, Y.¹ Eliyahu, S.² Sakaguchi, K.³ Robbins, P.F.⁴ Rivoltini, L.⁵ Yannelli, J.R.⁶ Appella, E.⁷ Rosenverg, S.A.⁸

3
- 0029053749
- Identification of an immunodominant peptide of HER2/neu proto-oncogene recognized by ovarian tumor specific cytotoxic T lymphocytes lines
- (1995) J. Exp. Med. , vol.181 , pp. 2109-2117
- Fisk, B.¹ Blevins, T.L.² Wharton, J.³ Ioannides, C.⁴

4
- 0032530575
- Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide
- (1998) J. Immunol. , vol.161 , pp. 3186-3194
- Correale, P.¹ Walmsley, K.² Zaremba, S.³ Zhu, M.⁴ Schlom, J.⁵ Tsang, K.Y.⁶

5
- 0032472799
- A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes
- (1998) J. Exp. Med. , vol.187 , pp. 277-288
- Shichijo, S.¹ Nakao, M.² Imai, Y.³ Takasu, H.⁴ Kawamoto, M.⁵ Niiya, F.⁶ Yang, D.⁷ Toh, Y.⁸ Yamana, H.⁹ Itoh, K.¹⁰

6
- 0034234953
- Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer
- (2000) Cancer Res. , vol.60 , pp. 3550-3558
- Kawano, K.¹ Gomi, S.² Tanaka, K.³ Tsuda, N.⁴ Kamura, T.⁵ Itoh, K.⁶ Yamada, A.⁷

7
- 0031890206
- Immunologic and therapeutic evaluation of synthetic peptide vaccine for the treatment of patients with metastatic melanoma
- (1998) Nat. Med. , vol.4 , pp. 321-327
- Rosenberg, S.A.¹ Yang, J.C.² Schwartzentruber, D.J.³ Hwu, P.⁴ Marincola, F.M.⁵ Topalian, S.L.⁶ Restifo, N.P.⁷ Dudley, M.E.⁸ Schwarz, S.L.⁹ Spiess, P.J.¹⁰ Wunderlich, J.R.¹¹ Parkhurst, M.A.¹² Kawakami, Y.¹³ Seipp, C.A.¹⁴ Einhorn, J.H.¹⁵ White, D.E.¹⁶

8
- 0031941423
- Vaccination of melanoma patients with peptide- or tumor lysate pulsed dendritic cells
- (1998) Nat. Med. , vol.4 , pp. 328-332
- Nestle, F.O.¹ Alijagic, S.² Gilliet, M.³ Sun, Y.⁴ Grabbe, S.⁵ Dummer, R.⁶ Burg, G.⁷ Schadendorf, D.⁸

9
- 0033579934
- Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
- (1999) Int. J. Cancer , vol.80 , pp. 219-230
- Marchand, M.¹ Van Baren, N.² Weynants, P.³ Brichard, V.⁴ Dréno, B.⁵ Tessier, M.H.⁶ Rankin, E.⁷ Parmiani, G.⁸ Arienti, F.⁹ Humblet, Y.¹⁰ Bourlond, A.¹¹ Vanwijck, R.¹² Liénard, D.¹³ Beauduin, M.¹⁴ Dietrich, P.Y.¹⁵ Russo, V.¹⁶ Kerger, J.¹⁷ Masucci, G.¹⁸ Jäger, E.¹⁹ De Greve, J.²⁰ more..

10
- 0032724112
- Phase I trial of a MART-1 peptide vaccine with incomplete Freund’s adjuvant for resected high-risk melanoma
- (1999) Clin. Cancer Res. , vol.5 , pp. 2756-2765
- Wang, F.¹ Bade, E.² Kuniyoshi, C.³ Spears, L.⁴ Jeffery, G.⁵ Marty, V.⁶ Groshen, S.⁷ Weber, J.⁸

11
- 0038691976
- Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
- (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 4760-4765
- Jager, E.¹ Nagata, Y.² Gnjatic, S.³ Wada, H.⁴ Stockert, E.⁵ Karbach, J.⁶ Dunbar, P.R.⁷ Lee, S.Y.⁸ Jungbluth, A.⁹ Jager, D.¹⁰ Arand, M.¹¹ Ritter, G.¹² Cerundolo, V.¹³ Dupont, B.¹⁴ Chen, Y.T.¹⁵ Old, L.J.¹⁶ Knuth, A.¹⁷

12
- 0035281522
- Irinotecan in the treatment of colorectal cancer: Clinical overview
- (2001) J. Clin. Oncol. , vol.19 , pp. 1501-1518
- Udo, V.¹ Andreas, H.² Wolf, A.³ Shousong, C.⁴ Siegfried, S.⁵ Youcef, M.R.⁶

13
- 0344109583
- Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
- (1998) J. Clin. Oncol. , vol.16 , pp. 301-308

14
- 0031014627
- Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
- (1997) J. Clin. Oncol. , vol.15 , pp. 251-260
- Rougier, P.¹ Bugat, R.² Douillard, J.Y.³ Culine, S.⁴ Suc, E.⁵ Brunet, P.⁶ Becouarn, Y.⁷ Ychou, M.⁸ Marty, M.⁹ Extra, J.M.¹⁰ Bonneterre, J.¹¹ Adenis, A.¹² Seitz, J.F.¹³ Ganem, G.¹⁴ Namer, M.¹⁵ Conroy, T.¹⁶ Negrier, S.¹⁷ Merrouche, Y.¹⁸ Burki, F.¹⁹ Mousseau, M.²⁰ Herait, P.²¹ Mahjoubi, M.²² more..

15
- 0033567098
- Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients
- (1999) Cancer Res. , vol.59 , pp. 4056-4063
- Yang, D.¹ Nakao, M.² Shichijo, S.³ Sasatomi, T.⁴ Takasu, H.⁵ Matsumoto, H.⁶ Mori, K.⁷ Hayashi, A.⁸ Yamana, H.⁹ Shirouzu, K.¹⁰ Itoh, K.¹¹

16
- 0033756324
- Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes
- (2000) Int. J. Cancer , vol.88 , pp. 633-639
- Ito, M.¹ Shichijo, S.² Miyagi, Y.³ Kobayashi, T.⁴ Tsuda, N.⁵ Yamada, A.⁶ Saito, N.⁷ Itoh, K.⁸

17
- 85007640630
- Expression of tumor-rejection antigens in colorectal cancers
- (2001) Cancer (Phila.)
- Sasatomi, T.¹ Suefuji, Y.² Miyagi, Y.³ Ogata, H.⁴ Akagi, T.⁵ Shirouzu, K.⁶ Itoh, K.⁷

18
- 0035452417
- Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS 1: A possible regulation of splicing by a complex formation
- (2001) Int. J. Cancer , vol.93 , pp. 623-629
- Harada, K.¹ Yamada, Y.² Yang, D.³ Itoh, K.⁴ Shichijo, S.⁵

19
- 0035105231
- Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases
- (2001) Eur. J. Immunol. , vol.31 , pp. 323-332
- Harashima, N.¹ Tanaka, K.² Sasatomi, T.³ Shimizu, K.⁴ Miyagi, Y.⁵ Yamada, A.⁶ Tamura, M.⁷ Yamana, H.⁸ Itoh, K.⁹ Shichijo, S.¹⁰

20
- 0034594628
- New guidelines to evaluate the response to treatment in solid tumors
- European Organization for Research and treatment of Cancer. National Cancer Institute of the United States, National Cancer Institute of Canada
- (2000) J. Natl. Cancer Inst. , vol.92 , pp. 205-216
- Therasse, P.¹ Arbuck, S.G.² Eisenhauer, E.A.³ Wanders, J.⁴ Kaplan, R.S.⁵ Rubinstein, L.⁶ Verweij, J.⁷ Van Glabbeke, M.⁸ Van Oosterom, A.T.⁹ Christian, M.C.¹⁰ Gwyther, S.G.¹¹

21
- 0019468220
- Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis
- (1981) J. Immunol. , vol.126 , pp. 1614-1619
- Taswell, C.¹

22
- 17444454475
- Toxicity grading criteria of the Japan Clinical Oncology Group
- Committee of the Japan Clinical Oncology Group
- (1993) Jpn. J. Clin. Oncol. , vol.23 , pp. 250-257
- Tobinai, K.¹ Kohno, A.² Shimada, Y.³ Watanabe, T.⁴ Tamura, T.⁵ Takeyama, K.⁶ Narabayashi, M.⁷ Fukutomi, T.⁸ Kondo, H.⁹ Shimoyama, M.¹⁰

23
- 0035815437
- Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
- (2001) Science (Wash. DC) , vol.292 , pp. 69-74
- Amara, R.R.¹ Villinger, F.² Altman, J.D.³ Lydy, S.H.⁴ O’Neil, S.P.⁵ Staprans, S.I.⁶ Montefiori, D.C.⁷ Xu, Y.⁸ Herndon, J.G.⁹ Wyatt, L.S.¹⁰ Candido, M.A.¹¹ Kozyr, N.L.¹² Earl, P.L.¹³ Smith, J.M.¹⁴ Ma, H.-L.¹⁵ Grimm, B.D.¹⁶ Hulsey, M.L.¹⁷ Miller, J.¹⁸ McClure, H.M.¹⁹ McNicholl, J.M.²⁰ Moss, B.²¹ Robinson, H.L.²² more..

24
- 0035328683
- Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
- (2001) Cancer Res. , vol.61 , pp. 3689-3697
- Machiels, J.-P.H.¹ Reilly, R.T.² Emens, L.A.³ Ercolini, A.M.⁴ Lei, R.Y.⁵ Weintraub, D.⁶ Okoye, F.I.⁷ Jaffee, E.M.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.